Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational research.
Olverembatinib 是一种调节脂质代谢的多激酶抑制剂,用于治疗晚期琥珀酸脱氢酶缺乏型胃肠道间质瘤:一项 1b 期研究和转化研究。
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02456-9
Qiu Hai-Bo, Liang Zhiyan, Yang Jing, Zhou Ye, Zhou Zhi-Wei, Wan Xiang-Bin, Li Ning, Tao Kai-Xiong, Li Yong, Wu Xin, Yang Chen, Chen Zi, Wang Hengbang, Men Lichuang, Xiong Yan, Liu Lihui, Yang Dajun, Zhai Yifan, Xu Rui-Hua